Published: 26 August 2022

European Heart Journal, Volume 43, Issue 41, 1 November 2022

This is the first European Society of Cardiology (ESC) guideline on cardio-oncology. The aim of this guideline is to help all the healthcare professionals providing care to oncology patients before, during, and after their cancer treatments with respect to their cardiovascular health and wellness. This guideline provides guidance on the definitions, diagnosis, treatment, and prevention of cancer therapy-related CV toxicity, and the management of CV disease caused directly or indirectly by cancer. This area of medicine has limited trials and evidence to base decision making and, where evidence is limited, this guideline provides the consensus of expert opinion to guide healthcare professionals.